Stock Ticker

  • Loading stock data...

Traders Look Towards Psoriasis Trials To Clear Investment Complexion (CTIX)

Before the market opened this morning after the Labor Day weekend, Cellceutix (OTC: CTIX) announced that it had selected Dr. Reddy’s Laboratory (NYSE: RDY) to manufacture the drug Purisol for the treatment of psoriasis. Cellceutix¬†plans to commence phase two and three clinical trials upon completion of the manufacturing process. In tests involving mice, Purisol demonstrated […]

Sign Up To Get Our Latest Stocks Alerts